Cerity Partners LLC Dexcom Inc Transaction History

Cerity Partners LLC

$44.7 Billion
Q3 2024

A detailed history of Cerity Partners LLC transactions in Dexcom Inc stock. As of the latest transaction made, Cerity Partners LLC holds 60,050 shares of DXCM stock, worth $4.67 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

60,050

Previous 20,706 190.01%

Holding current value

$4.67 Million

Previous $2.35 Million 71.45%

% of portfolio

0.01%

Previous 0.01%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$64.0 - $116.06 $2.52 Million - $4.57 Million	39,344 Added 190.01%	60,050 $4.02 Million
Q2 2024 Aug 13, 2024	SELL	$110.31 - $140.45 $615,309 - $783,430	-5,578 Reduced 21.22%	20,706 $2.35 Million
Q1 2024 May 14, 2024	SELL	$114.22 - $140.1 $50 Million - $61.3 Million	-437,689 Reduced 94.34%	26,284 $3.65 Million
Q4 2023 Jan 26, 2024	BUY	$75.49 - $124.16 $34.4 Million - $56.6 Million	456,097 Added 5790.97%	463,973 $57.6 Million
Q3 2023 Nov 13, 2023	SELL	$86.06 - $137.93 $749,152 - $1.2 Million	-8,705 Reduced 52.5%	7,876 $734,000
Q2 2023 Aug 14, 2023	BUY	$112.47 - $130.98 $413,102 - $481,089	3,673 Added 28.46%	16,581 $2.13 Million
Q1 2023 May 11, 2023	BUY	$104.0 - $122.92 $16,120 - $19,052	155 Added 1.22%	12,908 $1.5 Million
Q4 2022 Feb 15, 2023	BUY	$84.98 - $122.67 $453,623 - $654,812	5,338 Added 71.99%	12,753 $1.44 Million
Q3 2022 Nov 10, 2022	SELL	$76.35 - $94.18 $21,988 - $27,123	-288 Reduced 3.74%	7,415 $597,000
Q2 2022 Aug 10, 2022	BUY	$67.99 - $132.89 $425,277 - $831,226	6,255 Added 431.98%	7,703 $575,000
Q1 2022 Apr 25, 2022	SELL	$94.08 - $130.2 $52,872 - $73,172	-562 Reduced 27.96%	1,448 $743,000
Q4 2021 Feb 14, 2022	BUY	$129.87 - $162.82 $84,675 - $106,158	652 Added 48.01%	2,010 $1.08 Million
Q3 2021 Oct 25, 2021	SELL	$106.71 - $143.18 $3,521 - $4,724	-33 Reduced 2.37%	1,358 $743,000
Q2 2021 Aug 11, 2021	BUY	$80.99 - $107.93 $1,295 - $1,726	16 Added 1.16%	1,391 $594,000
Q1 2021 Aug 11, 2021	BUY	$84.79 - $104.74 $84 - $104	1 Added 0.07%	1,375 $494,000
Q1 2021 May 12, 2021	BUY	$84.79 - $104.74 $14,583 - $18,015	172 Added 14.31%	1,374 $494,000
Q4 2020 Feb 11, 2021	BUY	$78.0 - $104.5 $702 - $940	9 Added 0.75%	1,202 $444,000
Q3 2020 Nov 12, 2020	BUY	$95.51 - $112.95 $32,664 - $38,628	342 Added 40.19%	1,193 $492,000
Q2 2020 Aug 14, 2020	SELL	$62.68 - $105.34 $6,644 - $11,166	-106 Reduced 11.08%	851 $345,000
Q1 2020 May 14, 2020	BUY	$47.79 - $75.63 $334 - $529	7 Added 0.74%	957 $258,000
Q4 2019 Feb 14, 2020	BUY	$36.62 - $57.29 $34,789 - $54,425	950 New	950 $208,000
Q1 2019 May 14, 2019	SELL	$28.07 - $38.18 $67,311 - $91,555	-2,398 Closed	0 $0
Q4 2018 Feb 06, 2019	BUY	$26.99 - $37.37 $26,450 - $36,622	980 Added 69.11%	2,398 $287,000
Q3 2018 Nov 15, 2018	BUY	$23.35 - $36.72 $33,110 - $52,068	1,418 New	1,418 $203,000

Others Institutions Holding DXCM

# of Institutions

1,015

Shares Held

352M

Call Options Held

5.51M

Put Options Held

5.6M

View Full List

About DEXCOM INC

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $30.1B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

More about DXCM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cerity Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cerity Partners LLC with notifications on news.

Account

Cerity Partners LLC Dexcom Inc Transaction History